Maps food- and herb-derived bioactives to molecular targets using disease models, metabolomics and systems pharmacology. Focus on inflammation and immunometabolic crosstalk across skin, gut and liver, clarifying cell-death and signaling pathways to inform therapeutic and nutraceutical leads.